期刊文献+

273例癫痫患儿血清丙戊酸浓度和剂量分析 被引量:11

Relationship of dose and serum concentration of valproic acid in 273 cases of children with epilepsy
原文传递
导出
摘要 目的:研究丙戊酸钠治疗癫痫的量-效关系,为临床癫痫患儿合理应用丙戊酸钠提供参考。方法:回顾性分析我院采用荧光偏振免疫分析法测定的273例癫痫患儿血清丙戊酸浓度及其使用的丙戊酸钠剂量。结果:要达到相似的血清丙戊酸浓度,不同年龄组的癫痫患儿丙戊酸钠给药剂量有差异,1~3岁患儿所需的剂量最大。服用相似剂量不同剂型的丙戊酸钠,缓释片的平均血药浓度明显高于溶液剂和普通片剂。血清丙戊酸浓度与按体表面积计算的日剂量相关性优于按体质量计算的日剂量。结论:血清丙戊酸浓度与剂量相关性差,个体差异大,临床上在使用丙戊酸钠治疗癫痫患儿时,应监测血药浓度并实行个体化给药。 OBJECIIVE To study the dose-effect relationship of sodium valproate treatment for children with epilepsy for clinical application of epilepsy in children. METHODS The concentration of serum valproic acid was detected by fluorescence polarization immunoassay (FPIA) in 273 cases of children with epilepsy. RESULTS The dose to reach similar valproic acid ser um concentration was significantly different among different age groups, 1 to 3-year-old children required the highest dose. Taking similar dose of different preparations of sodium valproate, the average serum concentration of sustained-release tablet was significantly higher than that of the general solution and tablet. The correlation of valproic acid serum concentration and daily dose according to body surface area was better than that according to body weight. CONCLUSION The valproic acid serum concentration was poorly correlated with the dose. It is suggested to monitor the serum concentration and carry out individual administration in the clinical application of sodium valproate in the treatment of epilepsy in children.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第17期1444-1447,共4页 Chinese Journal of Hospital Pharmacy
基金 浙江省药学会医院药学科研专项基金项目(编号:2010ZYY05)
关键词 丙戊酸钠 血药浓度 癫痫 儿童 剂量 sodium valproate serum concentration epilepsy children dose
  • 相关文献

参考文献5

二级参考文献36

  • 1焦正,钟明康,胡敏,施孝金,李中东,张静华,王大猷,王宏图.丙戊酸清除率的群体药动学模型的建立[J].中国医院药学杂志,2004,24(9):515-517. 被引量:10
  • 2王刚,谷容,刘彬,贾运涛.儿童丙戊酸群体药动学[J].中国医院药学杂志,2004,24(12):735-738. 被引量:5
  • 3钟盛林,冯赛华,姜云平,吴苏澄.癫痫患儿丙戊酸钠药物动力学测定[J].实用儿科临床杂志,1995,10(3):163-164. 被引量:6
  • 4Shorvon SD, Dreifuss F, Fish D, et al. The treatment of epilepsy [M]. ed 3. London: Blackwell Science, 1996. 138~425.
  • 5Guberman A, Bruni J. Essentials of clinical epilepsy[M]. ed 2.Boston: Butterworth - Heinemann, 1999. 207.
  • 6Mattson RH, Cramer JA. Collins JF. Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures [J]. Neurology, 1996,47:68~76.
  • 7Brodie MJ, Dichter MA. Antiepileptic drugs[J]. N Engl J Med, 1996,334:168~ 175.
  • 8Devinsky O. Patients with refractory seizures[J]. N Engl J Med, 1999,340: 1565~1570.
  • 9Perucca E. The clinical pharmacokinetics of the new antiepileptic drugs[J]. Epilepsia, 1999,40:S 7~13.
  • 10Perucca E. Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs[J]. Epilepsia, 1996,37: S 8~13.

共引文献66

同被引文献85

引证文献11

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部